InnoCare Pharma Limited (9969.HK)

HKD 6.1

(0.16%)

Net Income Summary of InnoCare Pharma Limited

InnoCare Pharma Limited's latest annual net income in 2023 was -631.26 Million CNY , up 27.58% from previous year.
InnoCare Pharma Limited's latest quarterly net income in 2024 Q1 was -142.4 Million CNY , down -42.26% from previous quarter.
InnoCare Pharma Limited reported an annual net income of -871.65 Million CNY in 2022, down -1207.23% from previous year.
InnoCare Pharma Limited reported an annual net income of -66.67 Million CNY in 2021, up 85.6% from previous year.
InnoCare Pharma Limited reported a quarterly net income of -119.43 Million CNY for 2024 Q2, up 16.13% from previous quarter.
InnoCare Pharma Limited reported a quarterly net income of -631.26 Million CNY for 2023 FY, up 27.58% from previous quarter.

Annual Net Income Chart of InnoCare Pharma Limited (2023 - 2017)

Historical Annual Net Income of InnoCare Pharma Limited (2023 - 2017)

Year	Net Income	Net Income Growth
2023	-631.26 Million CNY	27.58%
2022	-871.65 Million CNY	-1207.23%
2021	-66.67 Million CNY	85.6%
2020	-463.16 Million CNY	78.34%
2019	-2.13 Billion CNY	-288.86%
2018	-549.95 Million CNY	-60.93%
2017	-341.73 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q1	-142.4 Million CNY	-42.26%
2024 Q2	-119.43 Million CNY	16.13%
2023 FY	-631.26 Million CNY	27.58%
2023 Q4	-100.09 Million CNY	8.13%
2023 Q3	-108.95 Million CNY	73.41%
2023 Q1	-12.4 Million CNY	76.34%
2023 Q2	-409.8 Million CNY	-3203.15%
2022 Q4	-52.44 Million CNY	86.65%
2022 Q3	-392.8 Million CNY	-21.57%
2022 Q2	-323.1 Million CNY	-173.25%
2022 Q1	-118.24 Million CNY	22.44%
2022 FY	-871.65 Million CNY	-1207.23%
2021 Q1	-104.7 Million CNY	-269.93%
2021 Q3	297.32 Million CNY	383.96%
2021 Q4	-152.45 Million CNY	-151.28%
2021 Q2	-104.7 Million CNY	0.0%
2021 FY	-66.67 Million CNY	85.6%
2020 FY	-463.16 Million CNY	78.34%
2020 Q1	-167.39 Million CNY	88.76%
2020 Q3	-28.3 Million CNY	83.09%
2020 Q2	-167.39 Million CNY	0.0%
2020 Q4	-28.3 Million CNY	0.0%
2019 Q3	-334.96 Million CNY	-108.5%
2019 Q2	-160.65 Million CNY	0.0%
2019 Q1	-160.65 Million CNY	-80.44%
2019 FY	-2.13 Billion CNY	-288.86%
2019 Q4	-1.48 Billion CNY	-344.54%
2018 Q3	-180.93 Million CNY	-29.53%
2018 Q4	-89.03 Million CNY	50.79%
2018 Q1	-139.68 Million CNY	0.0%
2018 Q2	-139.68 Million CNY	0.0%
2018 FY	-549.95 Million CNY	-60.93%
2017 FY	-341.73 Million CNY	0.0%

Peer Net Income Comparison of InnoCare Pharma Limited

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	990.658%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	3759.496%